WO2021086081A1 - Manufacture of photo-crosslinkable biodegradable tissue adhesive - Google Patents

Manufacture of photo-crosslinkable biodegradable tissue adhesive Download PDF

Info

Publication number
WO2021086081A1
WO2021086081A1 PCT/KR2020/014955 KR2020014955W WO2021086081A1 WO 2021086081 A1 WO2021086081 A1 WO 2021086081A1 KR 2020014955 W KR2020014955 W KR 2020014955W WO 2021086081 A1 WO2021086081 A1 WO 2021086081A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
adhesive
hama
photo
integer
Prior art date
Application number
PCT/KR2020/014955
Other languages
French (fr)
Korean (ko)
Inventor
양승윤
박삼대
이혜선
Original Assignee
부산대학교 산학협력단
주식회사 에스엔비아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200142804A external-priority patent/KR102515178B1/en
Application filed by 부산대학교 산학협력단, 주식회사 에스엔비아 filed Critical 부산대학교 산학협력단
Publication of WO2021086081A1 publication Critical patent/WO2021086081A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/58Adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Definitions

  • the present invention relates to a photo-crosslinkable biodegradable tissue adhesive and a method of manufacturing the same.
  • Medical tissue adhesives are used for the purpose of healing wounds by protecting the hemostasis, bonding, or treatment area of the wound.
  • fibrin-based tissue adhesives using the blood coagulation process in the body have high biocompatibility, but have a disadvantage of low adhesion to mucous membranes and wet tissues.
  • a photo-crosslinked tissue adhesive capable of maintaining high adhesion to the tissue by forming a hydrogel on the fly by light such as UV is attracting attention.
  • hyaluronic acid which is a constituent of various tissues in the human body, can help in wound recovery, and thus can help not only wound closure but also tissue regeneration with the introduction of the optical crosslinking group.
  • HAMA hyaluronic acid methacrylate
  • An object of the present invention is to provide a hyaluronic acid compound having excellent elongation and excellent adhesion to skin and mucous membranes.
  • Another object of the present invention is to provide a hydrogel or biodegradable tissue adhesive formed through a photocrosslinking reaction using the hyaluronic acid compound.
  • another object of the present invention is to provide a biodegradable tissue adhesive in which the hyaluronic acid compound and the hyaluronic acid compound having a different photocrosslink length are introduced in order to control the physical properties of the biodegradable tissue adhesive.
  • the present invention provides a compound represented by the following formula (1).
  • n is an integer of 1 to 10,000, and X 1 to X 4 may be the same or different, respectively, and are OH or a substituent of Formula 1-1.
  • p or q are each an integer of 0 to 10.
  • the present invention provides a hydrogel comprising the compound of Formula 1 and formed through a photocrosslinking reaction.
  • the present invention provides a biodegradable tissue adhesive comprising the compound of Formula 1 above.
  • the present invention provides a composition comprising further mixing a hyaluronic acid methacrylate (HAMA) compound with the compound of Formula 1 above.
  • HAMA hyaluronic acid methacrylate
  • the present invention provides a hydrogel comprising the composition, characterized in that formed through a photo-crosslinking reaction.
  • the present invention provides a biodegradable tissue adhesive comprising the composition.
  • Hyaluronic acid butylacrylate (HABA) prepared according to the present invention has excellent elongation and excellent adhesion to skin and mucous membrane tissues.
  • HAMA hyaluronic acid methacrylate
  • HA hyaluronic acid methacrylate
  • It can be used as a medical hemostatic agent, wound coating agent, anti-adhesion agent, cell culture support, 3D printer bioink, and bio-coating material.
  • HAMA is a diagram showing the elongation of HAMA, HABA, and HAPA.
  • FIG. 4 is a view showing the change in tensile strength according to the mixing ratio of HAMA and HABA.
  • FIG. 5 is a view showing the change in tensile strength according to the mixing ratio of HAMA and HAPA.
  • FIG. 6 is a diagram showing the results of a skin adhesion test of an adhesive in which HAMA, HAMA and HAPA are mixed.
  • FIG. 7 is a diagram showing the results of a test result of adhesion of an adhesive mixed with HAMA and HAPA to the ocular mucosa.
  • the present inventors synthesized a material of hyaluronic acid butylacrylate (HABA), which is excellent in elongation and tissue adhesion, and is a light cross-linking type HA such as hyaluronic acid methacrylate (HAMA) and the HABA. It is possible to prepare tissue adhesives with desired adhesive properties and physical properties by mixing HAs with different crosslinking lengths, so that medical adhesives that can be used on various parts of the body, medical hemostatic agents, wound coating agents, anti-adhesion agents, cell culture supports, 3D printers The present invention was completed by finding that it can be usefully used as a bio-ink and a bio-coating material.
  • HABA hyaluronic acid butylacrylate
  • HAMA hyaluronic acid methacrylate
  • the present invention provides a compound represented by the following formula (1).
  • n is an integer of 1 to 10,000, and X 1 to X 4 may be the same or different, respectively, and are OH or a substituent of Formula 1-1.
  • p or q are each an integer of 0 to 10.
  • X 1 to X 4 may include at least one or more substituents of Formula 1-1, the rest may be hydroxy groups, and the substitution rate of the substituents of Formula 1-1 may be 1 to 400%.
  • n is an integer of 1 to 10,000
  • X 1 to X 4 includes at least one substituent of Formula 1-1
  • p or q in Formula 1-1 is an integer of 0 to 10, respectively. It is desirable.
  • Chemical Formula 1 is characterized by having an ethylenically unsaturated group in the hyaluronic acid repeating unit excellent in biocompatibility.
  • the compound represented by Formula 1 may be a compound represented by Formula 2 below.
  • n is an integer of 1 to 10,000.
  • the present invention provides a hydrogel comprising any one of the compounds represented by Chemical Formulas 1 to 2, and is formed through a photocrosslinking reaction.
  • the hydrogel may be used as a physiologically active material or a carrier for a drug delivery system, or as an implant material for tissue regeneration and filling, but is not limited thereto.
  • the present invention provides a biodegradable tissue adhesive comprising any one of the compounds represented by Chemical Formulas 1 to 2.
  • the compound is a photo-crosslinkable biodegradable tissue adhesive capable of maintaining a high adhesion to the tissue by forming a hydrogel through a crosslinking reaction by light.
  • the photo-crosslinking reaction as well as the crosslinking reaction by UV, if a photoinitiator having a different absorption wavelength is used, it may be possible to form a hydrogel according to the photo-crosslinking reaction in light of other wavelengths including visible light.
  • biodegradable tissue adhesive is made of medical adhesive, medical hemostatic agent, wound coating agent, anti-adhesion agent, medical hemostatic agent, wound coating agent, anti-adhesion agent, cell culture support, 3D printer bioink, and bio-coating material. It may be used for any one or more selected purposes from the group, but is not limited thereto.
  • hyaluronic acid methacrylate Conventional photo-crosslinked hyaluronic acid methacrylate (HAMA) has been used in limited fields due to lack of flexibility during photocrosslinking.
  • HABA hyaluronic acid butylacrylate
  • HAPA hyaluronic acid pentacrylate
  • the range of use can be broadened, and through this, it is expected to increase the adhesion of the tissue.
  • the present invention provides a composition characterized in that the hyaluronic acid methacrylate (HAMA) compound is further mixed with the compound represented by the following formula (1).
  • HAMA hyaluronic acid methacrylate
  • n is an integer of 1 to 10,000, and X 1 to X 4 may be the same or different, respectively, and are OH or a substituent of Formula 1-1.
  • p or q are each an integer of 0 to 10.
  • X 1 to X 4 may include at least one or more substituents of Formula 1-1, the rest may be hydroxy groups, and the substitution rate of the substituents of Formula 1-1 may be 1 to 400%.
  • n is an integer of 1 to 10,000
  • X 1 to X 4 includes at least one substituent of Formula 1-1
  • p or q in Formula 1-1 is an integer of 0 to 10, respectively. It is desirable.
  • Chemical Formula 1 is characterized by having an ethylenically unsaturated group in the hyaluronic acid repeating unit excellent in biocompatibility.
  • the compound represented by Formula 1 may be a composition represented by Formula 2 or Formula 3.
  • n is an integer of 1 to 10,000.
  • n is an integer of 1 to 10,000.
  • the HAMA and the compound represented by Chemical Formula 1 may be mixed in a weight ratio of 10:0 to 5:5, and preferably in a weight ratio of 7:3, but are not limited thereto.
  • the mechanical properties can be adjusted according to the mixing ratio of each compound of HAMA and HABA or HAMA and HAPA, and the flexibility can be increased than that of conventional HAMA, so that the range of use can be expanded to a moving part. I can.
  • the mixed composition of HAMA and HAPA can have excellent adhesion to not only skin but also mucosal tissues than simple HAMA.
  • the present invention provides a hydrogel comprising the composition, characterized in that formed through a photo-crosslinking reaction.
  • the methacrylate, butyl acrylate, and pentaacrylate are photo-crosslinking agents and react with the hyaluronic acid to obtain a photo-crosslinkable hydrogel.
  • the "photocrosslinking agent” refers to a compound capable of inducing a radical reaction in a reaction system by forming a radical by light irradiation, and a compound that is generally used as a photocrosslinker or a photoinitiator may be used as a photocrosslinker of the present invention, but , It is more preferable to use a photocrosslinking agent or a photoinitiator that is not toxic or weak in vivo.
  • the hydrogel may be used as a physiologically active material or a carrier for a drug delivery system, or as an implant material for tissue regeneration and filling, but is not limited thereto.
  • the present invention provides a biodegradable tissue adhesive comprising the composition.
  • the composition is a photo-crosslinkable biodegradable tissue adhesive capable of maintaining high adhesion to the tissue by forming a hydrogel by crosslinking reaction by light.
  • the photo-crosslinking reaction as well as the crosslinking reaction by UV, if a photoinitiator having a different absorption wavelength is used, it may be possible to form a hydrogel according to the photo-crosslinking reaction in light of other wavelengths including visible light.
  • biodegradable tissue adhesive is made of medical adhesive, medical hemostatic agent, wound coating agent, anti-adhesion agent, medical hemostatic agent, wound coating agent, anti-adhesion agent, cell culture support, 3D printer bioink, and bio-coating material. It may be used for any one or more selected purposes from the group, but is not limited thereto.
  • HA which is a component of various tissues in the human body, and which promotes tissue regeneration while being transparent, to develop a flexible and transparent tissue adhesive that has excellent adhesion to not only skin but also mucosal tissues.
  • HABA HA-Butylaacrylate
  • HABA hyaluronic acid methacrylate
  • HAMA hyaluronic acid methacrylate
  • the physical properties of the adhesive can be freely adjusted as described above, it is possible to develop a medical adhesive that can be used on various parts of the body.
  • the above technology can be applied to medical hemostatic agents, wound coating agents, anti-adhesion agents, cell culture supports, 3D printer bioinks, and biocoating materials, but any application is possible as long as it can be used as a bio-adhesive without limitation. Do.
  • HAPA hyaluronic acid pentacrylate
  • Tensile tests were performed on a test piece molded in a dogbone shape according to the ASTM method at a rate of 1 mm/min using a universal testing machine of AND Corporation. The elongation was analyzed by measuring the strain at the fracture point of the specimen.
  • the elongation tends to increase as the length of the optical crosslinking increases. It was confirmed that HABA can increase three times or more from 7.5 mm before stretching to 25.5 mm after stretching, and compared with HAMA, HABA and HAPA showed excellent elongation.
  • HAMA or HAMA and HAPA are mixed at 7:3, and the photoinitiator, lithium phenyl-2,4,6-triethylbenzoyl phosphinate (Lithium phenyl-2,4,6-trimethylbenzoyl phosphinate; LAP)
  • UV was irradiated for 5 seconds, and the adhesive strength was confirmed in a dynamic environment by bending.

Abstract

The present invention relates to the manufacture of a photo-crosslinkable biodegradable tissue adhesive, and provides a novel hyaluronic acid compound having excellent elongation and excellent adhesive force even in skin and mucosal tissues, in which the physical properties of the adhesive can be adjusted by mixing HAMA with a photo-crosslinkable HA having a different photo-crosslinkable length, and thus, the adhesive can be used as a medical adhesive that can be used in various sites of a body.

Description

광가교형 생분해성 조직접착제 제조Manufacture of photo-crosslinked biodegradable tissue adhesive
본 발명은 광가교형 생분해성 조직접착제 및 이의 제조방법에 관한 것이다.The present invention relates to a photo-crosslinkable biodegradable tissue adhesive and a method of manufacturing the same.
의료용 조직 접착제는 상처부위의 지혈이나 접합 또는 치료부위를 보호하여 상처회복을 목적으로 사용된다. Medical tissue adhesives are used for the purpose of healing wounds by protecting the hemostasis, bonding, or treatment area of the wound.
종래 시아노아크릴레이트 (cyanoacrylate) 계열의 조직 접착제는 빠른 접착성능을 보이지만, 젖은 표면에서 접착성과 유연성이 떨어지고 분해과정에서 포름알데히드와 같은 독성 부산물이 생성되어 생체적합성이 낮다. 또한, 형성된 접착층이 불투명하고 고르지 못하여, 안구 표면과 같이 높은 광투과성이 요구되는 표면에는 적용이 어려운 한계가 있어왔다. Conventional cyanoacrylate-based tissue adhesives show fast adhesion performance, but their adhesion and flexibility are poor on wet surfaces, and toxic by-products such as formaldehyde are generated during the decomposition process, resulting in low biocompatibility. In addition, since the formed adhesive layer is opaque and uneven, there has been a limitation that it is difficult to apply to a surface requiring high light transmittance, such as an eyeball surface.
또한, 체내 혈액의 응고과정을 이용한 피브린 (fibrin) 계열의 조직 접착제는 생체적합성은 높은 편이지만 점막과 젖은 조직에 접착력이 낮다는 단점이 있었다. In addition, fibrin-based tissue adhesives using the blood coagulation process in the body have high biocompatibility, but have a disadvantage of low adhesion to mucous membranes and wet tissues.
최근에 UV와 같은 빛에 의해 즉석에서 하이드로젤을 형성하여 조직과 높은 접착력을 유지할 수 있는 광가교형 조직접착제가 주목을 받고 있다. 이는 일반적으로 수용성 고분자에 광가교 그룹을 도입하여 광가교형 고분자를 제조하고 이를 녹인 용액에 빛을 조사하여 하이드로젤을 형성함으로써 원하는 조직에 높은 접착력을 달성할 수 있다.Recently, a photo-crosslinked tissue adhesive capable of maintaining high adhesion to the tissue by forming a hydrogel on the fly by light such as UV is attracting attention. In general, it is possible to achieve high adhesion to a desired tissue by forming a hydrogel by introducing a photo-crosslinking group into a water-soluble polymer to prepare a photo-crosslinking polymer, and irradiating light to a solution obtained by dissolving the photo-crosslinking group.
특히, 인체 내 다양한 조직의 구성성분인 히알루론산 (Hyaluronic acid, HA)은 상처회복에 도움을 줄 수 있어 광가교 그룹의 도입에 따라 상처 봉합뿐만 아니라 조직 재생에도 도움을 줄 수 있다. In particular, hyaluronic acid (HA), which is a constituent of various tissues in the human body, can help in wound recovery, and thus can help not only wound closure but also tissue regeneration with the introduction of the optical crosslinking group.
하지만, 기존의 광가교형 HA인 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)는 유연성이 떨어지고 물성 조절이 어려워 제한적인 분야에서만 활용될 수 있는 문제점이 있어왔다.However, hyaluronic acid methacrylate (HAMA), which is a conventional photo-crosslinked HA, has a problem that it can be used only in limited fields due to poor flexibility and difficulty in controlling physical properties.
따라서 유연하면서도 접착제의 물성을 손쉽게 조절할 수 있는 광가교형 조직접착제에 대한 연구가 필요한 실정이다.Therefore, there is a need for research on a light-crosslinked tissue adhesive that is flexible and can easily control the physical properties of the adhesive.
본 발명의 목적은 우수한 연신율과 피부, 점막조직에서도 우수한 접착력을 갖는 히알루론산 화합물을 제공하는 데에 있다.An object of the present invention is to provide a hyaluronic acid compound having excellent elongation and excellent adhesion to skin and mucous membranes.
또한, 본 발명의 다른 목적은 상기 히알루론산 화합물을 이용한 광가교 반응을 통해 형성되는 하이드로젤 또는 생분해성 조직 접착제를 제공하는 데에 있다.In addition, another object of the present invention is to provide a hydrogel or biodegradable tissue adhesive formed through a photocrosslinking reaction using the hyaluronic acid compound.
또한, 본 발명의 다른 목적은 생분해성 조직 접착제의 물성을 조절하기 위해 상기 히알루론산 화합물과 광가교 길이가 상이한 히알루론산 화합물을 도입한 생분해성 조직 접착제를 제공하는 데에 있다.In addition, another object of the present invention is to provide a biodegradable tissue adhesive in which the hyaluronic acid compound and the hyaluronic acid compound having a different photocrosslink length are introduced in order to control the physical properties of the biodegradable tissue adhesive.
상기 목적을 달성하기 위하여, 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.In order to achieve the above object, the present invention provides a compound represented by the following formula (1).
[화학식 1][Formula 1]
Figure PCTKR2020014955-appb-I000001
Figure PCTKR2020014955-appb-I000001
상기 화학식 1에서, In Formula 1,
n은 1 내지 10,000의 정수이고, X1~X4은 각각 동일하거나 다를 수 있으며, OH 또는 화학식 1-1의 치환기임.n is an integer of 1 to 10,000, and X 1 to X 4 may be the same or different, respectively, and are OH or a substituent of Formula 1-1.
[화학식 1-1][Formula 1-1]
Figure PCTKR2020014955-appb-I000002
Figure PCTKR2020014955-appb-I000002
상기 화학식 1-1에서,In Formula 1-1,
p 또는 q는 각각 0 내지 10의 정수임.p or q are each an integer of 0 to 10.
또한, 본 발명은 상기 화학식 1의 화합물을 포함하며, 광가교 반응을 통해 형성되는 것을 특징으로 하는 하이드로젤을 제공한다.In addition, the present invention provides a hydrogel comprising the compound of Formula 1 and formed through a photocrosslinking reaction.
또한, 본 발명은 상기 화학식 1의 화합물을 포함하는 생분해성 조직 접착제를 제공한다.In addition, the present invention provides a biodegradable tissue adhesive comprising the compound of Formula 1 above.
또한, 본 발명은 상기 화학식 1의 화합물에 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA) 화합물을 더 혼합하는 것을 특징으로 하는 조성물을 제공한다.In addition, the present invention provides a composition comprising further mixing a hyaluronic acid methacrylate (HAMA) compound with the compound of Formula 1 above.
또한, 본 발명은 상기 조성물을 포함하며, 광가교 반응을 통해 형성되는 것을 특징으로 하는 하이드로젤을 제공한다.In addition, the present invention provides a hydrogel comprising the composition, characterized in that formed through a photo-crosslinking reaction.
또한, 본 발명은 상기 조성물을 포함하는 생분해성 조직 접착제를 제공한다.In addition, the present invention provides a biodegradable tissue adhesive comprising the composition.
본 발명에 따라 제조된 히알루론산 부틸아크릴레이트(Hyaluronic acid butylacrylate; HABA)는 우수한 연신율과 피부, 점막조직에서도 우수한 접착력을 갖는 효과가 있다.Hyaluronic acid butylacrylate (HABA) prepared according to the present invention has excellent elongation and excellent adhesion to skin and mucous membrane tissues.
또한, 광가교형 HA인 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)와 광가교 길이가 상이한 HA을 혼합하여 접착제의 물성을 조절할 수 있어, 신체의 여러 부위에 사용할 수 있는 의료용 접착제로 이용될 수 있으며, 의료용 지혈제, 창상피복제, 유착방지제, 세포배양 지지체, 3D 프린터용 바이오 잉크(printer bioink), 바이오 코팅 재료로도 유용하게 활용 가능하다.In addition, it is possible to adjust the physical properties of the adhesive by mixing hyaluronic acid methacrylate (HAMA), which is a light-crosslinking type HA, and HA having a different light-crosslinking length, so that it can be used as a medical adhesive that can be used on various parts of the body. It can be used as a medical hemostatic agent, wound coating agent, anti-adhesion agent, cell culture support, 3D printer bioink, and bio-coating material.
도 1은 HAMA의 NMR 이미지이다.1 is an NMR image of HAMA.
도 2는 HAPA의 NMR 이미지이다.2 is an NMR image of HAPA.
도 3은 HAMA, HABA, HAPA의 연신율을 나타낸 도면이다.3 is a diagram showing the elongation of HAMA, HABA, and HAPA.
도 4는 HAMA와 HABA의 혼합비율에 따른 인장강도의 변화를 나타낸 도면이다.4 is a view showing the change in tensile strength according to the mixing ratio of HAMA and HABA.
도 5는 HAMA와 HAPA의 혼합비율에 따른 인장강도의 변화를 나타낸 도면이다.5 is a view showing the change in tensile strength according to the mixing ratio of HAMA and HAPA.
도 6은 HAMA, HAMA와 HAPA를 혼합한 접착제의 피부 접착력 테스트 결과를 나타낸 도면이다.6 is a diagram showing the results of a skin adhesion test of an adhesive in which HAMA, HAMA and HAPA are mixed.
도 7은 HAMA와 HAPA를 혼합한 접착제의 안점막조직 접착력 테스트 결과를 나타낸 도면이다.FIG. 7 is a diagram showing the results of a test result of adhesion of an adhesive mixed with HAMA and HAPA to the ocular mucosa.
이하에서는 본 발명을 구체적으로 설명한다.Hereinafter, the present invention will be described in detail.
본 발명자들은 연신율 및 조직 접착력이 우수한 히알루론산 부틸아크릴레이트(Hyaluronic acid butylacrylate; HABA)의 물질을 합성하였으며, 광가교형 HA인 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)와 상기 HABA와 같이 광가교 길이가 상이한 HA을 혼합하여 원하는 접착 특성 및 물성을 가진 조직 접착제를 제조할 수 있어, 신체의 여러 부위에 사용할 수 있는 의료용 접착제, 의료용 지혈제, 창상피복제, 유착방지제, 세포배양 지지체, 3D 프린터용 바이오 잉크, 바이오 코팅재료로 유용하게 이용될 수 있음을 밝혀내어 본 발명을 완성하였다.The present inventors synthesized a material of hyaluronic acid butylacrylate (HABA), which is excellent in elongation and tissue adhesion, and is a light cross-linking type HA such as hyaluronic acid methacrylate (HAMA) and the HABA. It is possible to prepare tissue adhesives with desired adhesive properties and physical properties by mixing HAs with different crosslinking lengths, so that medical adhesives that can be used on various parts of the body, medical hemostatic agents, wound coating agents, anti-adhesion agents, cell culture supports, 3D printers The present invention was completed by finding that it can be usefully used as a bio-ink and a bio-coating material.
본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.The present invention provides a compound represented by the following formula (1).
[화학식 1][Formula 1]
Figure PCTKR2020014955-appb-I000003
Figure PCTKR2020014955-appb-I000003
상기 화학식 1에서, In Formula 1,
n은 1 내지 10,000의 정수이고, X1~X4은 각각 동일하거나 다를 수 있으며, OH 또는 화학식 1-1의 치환기임.n is an integer of 1 to 10,000, and X 1 to X 4 may be the same or different, respectively, and are OH or a substituent of Formula 1-1.
[화학식 1-1][Formula 1-1]
Figure PCTKR2020014955-appb-I000004
Figure PCTKR2020014955-appb-I000004
상기 화학식 1-1에서,In Formula 1-1,
p 또는 q는 각각 0 내지 10의 정수임.p or q are each an integer of 0 to 10.
이때, X1~X4은 적어도 하나 이상의 화학식 1-1의 치환기를 포함하며, 나머지는 하이드록시기일 수 있고, 화학식 1-1의 치환기의 치환율은 1~400%가 될 수 있다.At this time, X 1 to X 4 may include at least one or more substituents of Formula 1-1, the rest may be hydroxy groups, and the substitution rate of the substituents of Formula 1-1 may be 1 to 400%.
특히, 상기 화학식 1에서 n은 1 내지 10,000의 정수이고, X1~X4은 적어도 하나 이상의 화학식 1-1의 치환기를 포함하며, 상기 화학식 1-1에서 p 또는 q는 각각 0 내지 10의 정수인 것이 바람직하다.In particular, in Formula 1, n is an integer of 1 to 10,000, X 1 to X 4 includes at least one substituent of Formula 1-1, and p or q in Formula 1-1 is an integer of 0 to 10, respectively. It is desirable.
상기와 같이 화학식 1은 생체적합성이 우수한 히알루론산 반복단위에 에틸렌성 불포화기를 갖는 것을 특징으로 한다.As described above, Chemical Formula 1 is characterized by having an ethylenically unsaturated group in the hyaluronic acid repeating unit excellent in biocompatibility.
또한, 상기 화학식 1로 표시되는 화합물은 하기 화학식 2로 표시되는 화합물일 수 있다.In addition, the compound represented by Formula 1 may be a compound represented by Formula 2 below.
[화학식 2][Formula 2]
Figure PCTKR2020014955-appb-I000005
Figure PCTKR2020014955-appb-I000005
상기 화학식 2에서, n은 1 내지 10,000의 정수임.In Formula 2, n is an integer of 1 to 10,000.
또한, 본 발명은 상기 화학식 1 내지 화학식 2로 표시되는 화합물 중 어느 한 화합물을 포함하며, 광가교 반응을 통해 형성되는 것을 특징으로 하는 하이드로젤을 제공한다.In addition, the present invention provides a hydrogel comprising any one of the compounds represented by Chemical Formulas 1 to 2, and is formed through a photocrosslinking reaction.
상기 하이드로젤은 생리활성물질 또는 약물 전달체용 담체나, 조직재생 및 충진용 임플란트 소재 등으로 활용 가능하지만, 이에 한정되는 것은 아니다.The hydrogel may be used as a physiologically active material or a carrier for a drug delivery system, or as an implant material for tissue regeneration and filling, but is not limited thereto.
또한, 본 발명은 상기 화학식 1 내지 화학식 2로 표시되는 화합물 중 어느 한 화합물을 포함하는 생분해성 조직 접착제를 제공한다.In addition, the present invention provides a biodegradable tissue adhesive comprising any one of the compounds represented by Chemical Formulas 1 to 2.
이때, 상기 화합물은 광에 의해 가교 반응이 일어나 하이드로젤(hydrogel)을 형성하여 조직과 높은 접착력을 유지할 수 있는 광가교형 생분해성 조직 접착제이다. 이때, 광 가교 반응은 UV에 의한 가교 반응 뿐 아니라, 흡수파장이 다른 광개시제를 사용하면 가시광선을 비롯한 다른 파장의 빛에서도 광 가교 반응에 따른 하이드로젤 형성이 가능할 수 있다.At this time, the compound is a photo-crosslinkable biodegradable tissue adhesive capable of maintaining a high adhesion to the tissue by forming a hydrogel through a crosslinking reaction by light. At this time, in the photo-crosslinking reaction, as well as the crosslinking reaction by UV, if a photoinitiator having a different absorption wavelength is used, it may be possible to form a hydrogel according to the photo-crosslinking reaction in light of other wavelengths including visible light.
또한, 상기 생분해성 조직 접착제는 의료용 접착제, 의료용 지혈제, 창상피복제, 유착방지제, 의료용 지혈제, 창상피복제, 유착방지제, 세포배양 지지체, 3D 프린터용 바이오 잉크(printer bioink), 바이오 코팅 재료로 이루어진 군에서 어느 하나 이상 선택되는 용도로 이용될 수 있지만, 이에 한정되는 것은 아니다.In addition, the biodegradable tissue adhesive is made of medical adhesive, medical hemostatic agent, wound coating agent, anti-adhesion agent, medical hemostatic agent, wound coating agent, anti-adhesion agent, cell culture support, 3D printer bioink, and bio-coating material. It may be used for any one or more selected purposes from the group, but is not limited thereto.
종래의 광가교형 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)는 광가교시 유연성이 부족하여 제한적인 분야에 활용되어 왔다. 이를 개선하기 위해 연신율이 우수한 히알루론산 부틸아크릴레이트(Hyaluronic acid butylacrylate; HABA) 또는 히알루론산 펜타크릴레이트(Hyaluronic acid Pentacrylate; HAPA)를 혼합하여 하이드로겔 조직접착제의 기계적 물성을 조절함으로써 움직임이 있는 부분에 사용범위를 넓힐 수 있고, 이를 통해 조직의 접착력 증대도 기대할 수 있다.Conventional photo-crosslinked hyaluronic acid methacrylate (HAMA) has been used in limited fields due to lack of flexibility during photocrosslinking. In order to improve this, hyaluronic acid butylacrylate (HABA) or hyaluronic acid pentacrylate (HAPA) with excellent elongation is mixed to adjust the mechanical properties of the hydrogel tissue adhesive to the moving part. The range of use can be broadened, and through this, it is expected to increase the adhesion of the tissue.
이에, 본 발명은 하기 화학식 1로 표시되는 화합물에 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA) 화합물을 더 혼합하는 것을 특징으로 하는 조성물을 제공한다.Accordingly, the present invention provides a composition characterized in that the hyaluronic acid methacrylate (HAMA) compound is further mixed with the compound represented by the following formula (1).
[화학식 1][Formula 1]
Figure PCTKR2020014955-appb-I000006
Figure PCTKR2020014955-appb-I000006
상기 화학식 1에서, In Formula 1,
n은 1 내지 10,000의 정수이고, X1~X4은 각각 동일하거나 다를 수 있으며, OH 또는 화학식 1-1의 치환기임.n is an integer of 1 to 10,000, and X 1 to X 4 may be the same or different, respectively, and are OH or a substituent of Formula 1-1.
[화학식 1-1][Formula 1-1]
Figure PCTKR2020014955-appb-I000007
Figure PCTKR2020014955-appb-I000007
상기 화학식 1-1에서,In Formula 1-1,
p 또는 q는 각각 0 내지 10의 정수임.p or q are each an integer of 0 to 10.
이때, X1~X4은 적어도 하나 이상의 화학식 1-1의 치환기를 포함하며, 나머지는 하이드록시기일 수 있고, 화학식 1-1의 치환기의 치환율은 1~400%가 될 수 있다.At this time, X 1 to X 4 may include at least one or more substituents of Formula 1-1, the rest may be hydroxy groups, and the substitution rate of the substituents of Formula 1-1 may be 1 to 400%.
특히, 상기 화학식 1에서 n은 1 내지 10,000의 정수이고, X1~X4은 적어도 하나 이상의 화학식 1-1의 치환기를 포함하며, 상기 화학식 1-1에서 p 또는 q는 각각 0 내지 10의 정수인 것이 바람직하다.In particular, in Formula 1, n is an integer of 1 to 10,000, X 1 to X 4 includes at least one substituent of Formula 1-1, and p or q in Formula 1-1 is an integer of 0 to 10, respectively. It is desirable.
상기와 같이 화학식 1은 생체적합성이 우수한 히알루론산 반복단위에 에틸렌성 불포화기를 갖는 것을 특징으로 한다.As described above, Chemical Formula 1 is characterized by having an ethylenically unsaturated group in the hyaluronic acid repeating unit excellent in biocompatibility.
또한, 상기 화학식 1로 표시되는 화합물은 하기 화학식 2 또는 화학식 3으로로 표시되는 조성물일 수 있다.In addition, the compound represented by Formula 1 may be a composition represented by Formula 2 or Formula 3.
[화학식 2][Formula 2]
Figure PCTKR2020014955-appb-I000008
Figure PCTKR2020014955-appb-I000008
상기 화학식 2에서, n은 1 내지 10,000의 정수임.In Formula 2, n is an integer of 1 to 10,000.
[화학식 3][Formula 3]
Figure PCTKR2020014955-appb-I000009
Figure PCTKR2020014955-appb-I000009
상기 화학식 3에서, n은 1 내지 10,000의 정수임.In Formula 3, n is an integer of 1 to 10,000.
이때, 상기 HAMA와 화학식 1로 표시되는 화합물은 10:0 내지 5:5의 중량비율로 혼합될 수 있으며, 바람직하게는 7:3의 중량비율로 혼합할 수 있으나, 이에 제한되는 것은 아니다.In this case, the HAMA and the compound represented by Chemical Formula 1 may be mixed in a weight ratio of 10:0 to 5:5, and preferably in a weight ratio of 7:3, but are not limited thereto.
본 발명의 일 실시예에 따르면, HAMA와 HABA 또는 HAMA와 HAPA의 각 화합물의 혼합비율에 따라 기계적 물성을 조절할 수 있으며, 종래 HAMA 보다 유연성이 증가될 수 있어, 움직임이 있는 부분에 사용범위를 넓힐 수 있다.According to an embodiment of the present invention, the mechanical properties can be adjusted according to the mixing ratio of each compound of HAMA and HABA or HAMA and HAPA, and the flexibility can be increased than that of conventional HAMA, so that the range of use can be expanded to a moving part. I can.
또한, HAMA와 HAPA 혼합 조성물은 단순 HAMA 보다 피부뿐만 아니라 점막조직에서도 탁월한 접착력을 지닐 수 있음을 확인하였다.In addition, it was confirmed that the mixed composition of HAMA and HAPA can have excellent adhesion to not only skin but also mucosal tissues than simple HAMA.
또한, 본 발명은 상기 조성물을 포함하며, 광가교 반응을 통해 형성되는 것을 특징으로 하는 하이드로젤을 제공한다. In addition, the present invention provides a hydrogel comprising the composition, characterized in that formed through a photo-crosslinking reaction.
상기 메타크릴레이트, 부틸아크릴레이트, 펜타아크릴레이트는 광가교제로, 상기 히알루론산과 반응하여 광가교성의 하이드로젤을 수득할 수 있다. 상기 "광가교제"는 광조사에 의해서 라디칼이 형성됨으로써 반응계 내에서 라디칼 반응을 유발할 수 있는 화합물을 의미하고, 통상적으로 광가교제 또는 광개시제로 사용되는 화합물은 본 발명의 광가교제로 사용될 수 있으나, 다만, 생체 내 독성이 없거나 미약한 광가교제 또는 광개시제를 사용하는 것이 보다 바람직하다.The methacrylate, butyl acrylate, and pentaacrylate are photo-crosslinking agents and react with the hyaluronic acid to obtain a photo-crosslinkable hydrogel. The "photocrosslinking agent" refers to a compound capable of inducing a radical reaction in a reaction system by forming a radical by light irradiation, and a compound that is generally used as a photocrosslinker or a photoinitiator may be used as a photocrosslinker of the present invention, but , It is more preferable to use a photocrosslinking agent or a photoinitiator that is not toxic or weak in vivo.
상기 하이드로젤은 생리활성물질 또는 약물 전달체용 담체나, 조직재생 및 충진용 임플란트 소재 등으로 활용 가능하지만, 이에 한정되는 것은 아니다.The hydrogel may be used as a physiologically active material or a carrier for a drug delivery system, or as an implant material for tissue regeneration and filling, but is not limited thereto.
또한, 본 발명은 상기 조성물을 포함하는 생분해성 조직 접착제를 제공한다.In addition, the present invention provides a biodegradable tissue adhesive comprising the composition.
이때, 상기 조성물은 광에 의해 가교 반응이 일어나 하이드로젤(hydrogel)을 형성하여 조직과 높은 접착력을 유지할 수 있는 광가교형 생분해성 조직 접착제이다. 이때, 광 가교 반응은 UV에 의한 가교 반응 뿐 아니라, 흡수파장이 다른 광개시제를 사용하면 가시광선을 비롯한 다른 파장의 빛에서도 광 가교 반응에 따른 하이드로젤 형성이 가능할 수 있다.In this case, the composition is a photo-crosslinkable biodegradable tissue adhesive capable of maintaining high adhesion to the tissue by forming a hydrogel by crosslinking reaction by light. At this time, in the photo-crosslinking reaction, as well as the crosslinking reaction by UV, if a photoinitiator having a different absorption wavelength is used, it may be possible to form a hydrogel according to the photo-crosslinking reaction in light of other wavelengths including visible light.
또한, 상기 생분해성 조직 접착제는 의료용 접착제, 의료용 지혈제, 창상피복제, 유착방지제, 의료용 지혈제, 창상피복제, 유착방지제, 세포배양 지지체, 3D 프린터용 바이오 잉크(printer bioink), 바이오 코팅 재료로 이루어진 군에서 어느 하나 이상 선택되는 용도로 이용될 수 있지만, 이에 한정되는 것은 아니다.In addition, the biodegradable tissue adhesive is made of medical adhesive, medical hemostatic agent, wound coating agent, anti-adhesion agent, medical hemostatic agent, wound coating agent, anti-adhesion agent, cell culture support, 3D printer bioink, and bio-coating material. It may be used for any one or more selected purposes from the group, but is not limited thereto.
본 발명에서는 인체 내 여러 조직의 구성성분이며, 투명하면서 조직재생을 촉진하는 HA에 길이가 다른 다양한 광가교 그룹을 도입하여 피부뿐만 아니라 점막조직에서도 탁월한 접착력을 지니고, 유연하면서도 투명한 조직 접착제를 개발하였다. 특히, 다른 광가교형 HA 유도체보다 HA-Butylaacrylate (HABA)는 우수한 연신율 및 접착 특성을 보였다. 또한, 유연하면서도 접착제의 물성을 손쉽게 조절하기 위해 광가교형 HA인 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)와 광가교 길이가 상이한 HA을 혼합하여 HA 내 광가교 그룹의 길이를 조절함으로써, 원하는 접착 특성 및 물성을 가진 조직 접착제를 제조할 수 있었다.In the present invention, various light-crosslinking groups of different lengths were introduced to HA, which is a component of various tissues in the human body, and which promotes tissue regeneration while being transparent, to develop a flexible and transparent tissue adhesive that has excellent adhesion to not only skin but also mucosal tissues. . In particular, HA-Butylaacrylate (HABA) showed superior elongation and adhesion properties than other photo-crosslinked HA derivatives. In addition, by mixing hyaluronic acid methacrylate (HAMA), which is a light-crosslinking type HA, and HA having a different light-crosslinking length, to adjust the length of the light-crosslinking group in the HA, A tissue adhesive having desired adhesive properties and physical properties could be prepared.
상기와 같이 접착제의 물성을 자유로이 조절할 수 있으므로 신체의 여러 부위에 사용할 수 있는 의료용 접착제의 개발이 가능하다. 또한, 상기 기술은 의료용 지혈제, 창상피복제, 유착방지제, 세포배양 지지체, 3D 프린터 바이오잉크(printer bioink) 및 바이오코팅 재료로의 응용이 가능하나, 이에 제한 없이 생체 접착제로 사용될 수 있으면 모두 응용 가능하다.Since the physical properties of the adhesive can be freely adjusted as described above, it is possible to develop a medical adhesive that can be used on various parts of the body. In addition, the above technology can be applied to medical hemostatic agents, wound coating agents, anti-adhesion agents, cell culture supports, 3D printer bioinks, and biocoating materials, but any application is possible as long as it can be used as a bio-adhesive without limitation. Do.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail through examples. These examples are only for describing the present invention in more detail, and that the scope of the present invention is not limited by these examples according to the gist of the present invention, to those of ordinary skill in the art to which the present invention pertains. It will be self-evident.
<합성예 1> 히알루론산 부틸아크릴레이트(Hyaluronic acid butylacrylate; HABA)의 합성<Synthesis Example 1> Synthesis of hyaluronic acid butylacrylate (HABA)
[반응식 1][Scheme 1]
Figure PCTKR2020014955-appb-I000010
Figure PCTKR2020014955-appb-I000010
상기 반응식 1에서와 같이, 정제수 100 ml에 히알루론산 10 g(26 mmol)을 녹이고 0-5 ℃로 냉각을 시킨다. 여기에 3-부테노익 무수물(3-butenoic anhydride) 52 mmol과 3M NaOH 100 ml 용액을 첨가한 후 2일간 교반하였다. 이 반응물을 에탄올에 침전하여 정제하고, 진공건조하여 히알루론산 부틸아크릴레이트(Hyaluronic acid butylacrylate; HABA)를 제조하였다. 수율: 85%, 1H-NMR (300 MHz, D2O):δ(ppm)= 5.9, 5.3, 5.2 (3H, CH=CH2), 4.5-4.3 (2H, CH2), 3.8-3.0(10H, CH), 2.9(2H, CH2), 1.8(3H, CH3).As in Reaction Scheme 1, 10 g (26 mmol) of hyaluronic acid is dissolved in 100 ml of purified water and cooled to 0-5°C. 52 mmol of 3-butenoic anhydride and 100 ml of 3M NaOH were added thereto, followed by stirring for 2 days. The reaction product was precipitated in ethanol, purified, and dried in vacuo to prepare hyaluronic acid butylacrylate (HABA). Yield: 85%, 1 H-NMR (300 MHz, D 2 O): δ(ppm)= 5.9, 5.3, 5.2 (3H, CH=CH 2 ), 4.5-4.3 (2H, CH 2 ), 3.8-3.0 (10H, CH), 2.9 (2H, CH 2 ), 1.8 (3H, CH 3 ).
<합성예 2> 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)의 합성<Synthesis Example 2> Synthesis of hyaluronic acid methacrylate (HAMA)
정제수 100 ml에 히알루론산 10 g(26 mmol)을 녹이고 0-5 ℃로 냉각시켰다. 여기에 메타크릴 무수물(methacrylic anhydride) 104 mmol 과 3M NaOH 100 ml 용액을 첨가한 후, 2일간 교반하였다. 이 반응물을 에탄올에 침전하여 정제하고, 진공건조하여 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)를 제조하였다(도 1 참조).10 g (26 mmol) of hyaluronic acid was dissolved in 100 ml of purified water and cooled to 0-5 °C. After adding 104 mmol of methacrylic anhydride and 100 ml of 3M NaOH, the mixture was stirred for 2 days. The reaction product was precipitated in ethanol, purified, and vacuum-dried to prepare hyaluronic acid methacrylate (HAMA) (see FIG. 1).
<합성예 3> 히알루론산 펜타크릴레이트(Hyaluronic acid Pentacrylate; HAPA)의 합성<Synthesis Example 3> Synthesis of Hyaluronic acid Pentacrylate (HAPA)
정제수 100 ml에 히알루론산 10 g(26 mmol)을 녹이고 0-5 ℃로 냉각시켰다. 여기에 4-펜테노익 무수물(4-pentenoic anhydride) 156 mmol 과 3M NaOH 100 ml 용액을 첨가한 후 2일간 교반하였다. 이 반응물을 에탄올에 침전하여 정제하고, 진공건조하여 히알루론산 펜타크릴레이트(Hyaluronic acid Pentacrylate; HAPA)를 제조하였다(도 2 참조).10 g (26 mmol) of hyaluronic acid was dissolved in 100 ml of purified water and cooled to 0-5 °C. After adding 156 mmol of 4-pentenoic anhydride and 100 ml of 3M NaOH, the mixture was stirred for 2 days. The reaction product was precipitated in ethanol, purified, and vacuum-dried to prepare hyaluronic acid pentacrylate (HAPA) (see FIG. 2).
<실시예 1> HAMA, HABA, HAPA 의 물성 측정<Example 1> Measurement of physical properties of HAMA, HABA, and HAPA
상기 합성예 1 내지 3을 통해 합성된 HAMA, HABA, HAPA의 연신율(Elongation)을 인장실험을 통해 측정하였다.The elongation of HAMA, HABA, and HAPA synthesized through Synthesis Examples 1 to 3 was measured through a tensile test.
인장실험은 AND사의 만능재료시험기 (Universal testing machine)를 사용하여 ASTM 방법에 따라 도그본(Dogbone) 형태로 성형된 시험편을 1 mm/min의 속도로 인장실험을 진행하였다. 연신율은 시편 파단점에서의 변형율을 측정하여 분석을 수행하였다.Tensile tests were performed on a test piece molded in a dogbone shape according to the ASTM method at a rate of 1 mm/min using a universal testing machine of AND Corporation. The elongation was analyzed by measuring the strain at the fracture point of the specimen.
그 결과, 도 3에서와 같이 광가교 길이가 길어짐에 따라 연신율이 증가하는 경향을 보였다. HABA는 인장 전 7.5 mm에서 인장 후 25.5 mm까지 3배 이상 늘어날 수 있음을 확인하였으며, HAMA와 비교하여 HABA, HAPA는 우수한 연신율을 보임을 확인하였다.As a result, as shown in FIG. 3, the elongation tends to increase as the length of the optical crosslinking increases. It was confirmed that HABA can increase three times or more from 7.5 mm before stretching to 25.5 mm after stretching, and compared with HAMA, HABA and HAPA showed excellent elongation.
<실시예 2> HABA를 이용한 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)의 물성 조절<Example 2> Adjustment of physical properties of hyaluronic acid methacrylate (HAMA) using HABA
Figure PCTKR2020014955-appb-I000011
Figure PCTKR2020014955-appb-I000011
상기 합성예 1, 2을 통해 합성된 HAMA와 HABA의 혼합비율을 중량비로 10:0, 7:3 및 5:5로 달리하여 혼합한 후, 인장강도를 측정하였다.The mixing ratios of HAMA and HABA synthesized through Synthesis Examples 1 and 2 were mixed at different weight ratios of 10:0, 7:3 and 5:5, and then the tensile strength was measured.
인장실험은 AND사의 만능재료시험기 (Universal testing machine)를 사용하여 ASTM 방법에 따라 도그본(Dogbone) 형태로 성형된 시험편을 1 mm/min의 속도로 측정하였으며, 응력-변형도 선도(Strain-stress curve)에서 최대 응력을 측정하였다.Tensile tests were conducted using AND's universal testing machine, and the specimen molded in a dogbone shape according to the ASTM method was measured at a speed of 1 mm/min. curve) was measured.
그 결과, 도 4와 같이, HAMA와 HABA의 혼합비율에 따라 기계적 강도가 달라짐을 확인하였다.As a result, as shown in FIG. 4, it was confirmed that the mechanical strength was changed according to the mixing ratio of HAMA and HABA.
<실시예 3> 히알루론산 펜타크릴레이트(Hyaluronic acid pentacrylate; HAPA)를 이용한 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA)의 물성 조절<Example 3> Adjustment of physical properties of hyaluronic acid methacrylate (HAMA) using hyaluronic acid pentacrylate (HAPA)
Figure PCTKR2020014955-appb-I000012
Figure PCTKR2020014955-appb-I000012
상기 합성예 1, 3을 통해 합성된 HAMA와 HAPA의 혼합비율을 중량비로 10:0, 9:1, 8:2, 7:3, 6:4 및 5:5로 달리하여 혼합한 후, 인장강도를 측정하였다.After mixing by varying the mixing ratio of HAMA and HAPA synthesized through Synthesis Examples 1 and 3 in a weight ratio of 10:0, 9:1, 8:2, 7:3, 6:4 and 5:5, tensile The strength was measured.
인장실험은 AND사의 만능재료시험기 (Universal testing machine)를 사용하여 ASTM 방법에 따라 도그본(Dogbone) 형태로 성형된 시험편을 1 mm/min의 속도로 측정하였으며, 응력-변형도 선도(Strain-stress curve)에서 최대 응력을 측정하였다.Tensile tests were performed on a specimen molded in a dogbone shape according to the ASTM method using a universal testing machine from AND at a speed of 1 mm/min. curve) was measured.
그 결과, 도 5와 같이, HAMA와 HAPA의 혼합비율에 따라 기계적 강도가 달라짐을 확인하였다.As a result, as shown in FIG. 5, it was confirmed that the mechanical strength was changed according to the mixing ratio of HAMA and HAPA.
<실시예 4> 동적환경에서 HAMA와 HAPA가 혼합된 접착제의 접착력 테스트<Example 4> Adhesion test of an adhesive mixed with HAMA and HAPA in a dynamic environment
HAMA와 HAPA를 혼합한 접착제의 접착성능을 평가하기 위해, HAMA, HAMA와 HAPA를 7:3으로 혼합한 접착제의 피부 접착력 테스트를 진행하였다.In order to evaluate the adhesion performance of the adhesive mixed with HAMA and HAPA, a skin adhesion test of the adhesive mixed with HAMA, HAMA and HAPA at 7:3 was conducted.
돼지피부의 표면에 HAMA 또는 HAMA와 HAPA를 7:3으로 혼합하고, 광개시제인 리튬 페닐-2,4,6-트리에틸벤조일 포스피네이트(Lithium phenyl-2,4,6-trimethylbenzoyl phosphinate; LAP)를 0.1 wt% 첨가한 접착제 용액을 도포한 후, UV를 5초 동안 조사하고, 구부려 동적 환경에서의 부착력을 확인하였다. On the surface of pig skin, HAMA or HAMA and HAPA are mixed at 7:3, and the photoinitiator, lithium phenyl-2,4,6-triethylbenzoyl phosphinate (Lithium phenyl-2,4,6-trimethylbenzoyl phosphinate; LAP) After applying the adhesive solution to which 0.1 wt% was added, UV was irradiated for 5 seconds, and the adhesive strength was confirmed in a dynamic environment by bending.
그 결과, 도 6과 같이, HAMA 단일 접착제는 90°이상 피부를 접었을 때(bending test), 유연성이 낮아 탈착이 되었으나, HAMA와 HAPA 혼합접착제는 유연성의 증가로 인해 90°정도의 구부림에도 부착을 유지함을 확인하였다.As a result, as shown in FIG. 6, when the HAMA single adhesive was folded over 90° (bending test), it was detached due to low flexibility, but the HAMA and HAPA mixed adhesive adhered to a bending of about 90° due to an increase in flexibility. It was confirmed that it was maintained.
<실시예 5> 점막조직에서 HAMA와 HAPA가 혼합된 접착제의 접착력 및 조직 회복력 테스트<Example 5> Adhesion and tissue resilience test of an adhesive mixed with HAMA and HAPA in mucosal tissue
습윤한 환경에서의 조직접착 유지력과 회복력을 확인하기 위해, HAMA와 HAPA를 7:3으로 혼합한 접착제의 안점막조직 접착력 테스트를 진행하였다.In order to check the tissue adhesion retention and resilience in a humid environment, an adhesive strength test of the adhesive mixed with HAMA and HAPA at 7:3 was performed.
토끼의 안점막에 수술용 나이프를 이용하여 인위적으로 절개하여 HAMA와 HAPA를 7:3으로 혼합하고, 광개시제인 리튬 페닐-2,4,6-트리에틸벤조일 포스피네이트(Lithium phenyl-2,4,6-trimethylbenzoyl phosphinate; LAP)를 0.1 wt% 첨가한 접착제 용액을 도포한 후, UV를 5초 동안 조사하고, 육안으로 부착력을 확인하였다.Using a surgical knife to artificially incise the rabbit's eye mucosa, and mix HAMA and HAPA at 7:3, and lithium phenyl-2,4,6-triethylbenzoyl phosphinate (Lithium phenyl-2,4) as a photoinitiator. ,6-trimethylbenzoyl phosphinate; LAP) 0.1 wt% added adhesive solution was applied, UV irradiated for 5 seconds, and visually confirmed adhesion.
그 결과, 도 7과 같이, HAMA와 HAPA가 7:3으로 혼합된 접착제를 적용한 경우, 상처회복동안 점막에 부착을 유지할 수 있었고, 이로 인해 절개부가 안정적으로 수복되어짐을 확인하였다. 그에 반해 접착제가 도포되지 않은 그룹은 절개부가 노출되어 균일하지 못한 조직의 회복이 이루어진 것을 확인하였다.As a result, it was confirmed that, as shown in FIG. 7, when an adhesive in which HAMA and HAPA were mixed at 7:3 was applied, adhesion to the mucous membrane could be maintained during wound recovery, and thus the incision was stably repaired. On the other hand, it was confirmed that the uneven tissue was recovered by exposing the incision in the group to which the adhesive was not applied.

Claims (12)

  1. 하기 화학식 1로 표시되는 화합물:Compound represented by the following formula (1):
    [화학식 1][Formula 1]
    Figure PCTKR2020014955-appb-I000013
    Figure PCTKR2020014955-appb-I000013
    상기 화학식 1에서, In Formula 1,
    n은 1 내지 10,000의 정수이고, X1~X4은 각각 동일하거나 다를 수 있으며, OH 또는 화학식 1-1의 치환기임.n is an integer of 1 to 10,000, and X 1 to X 4 may be the same or different, respectively, and are OH or a substituent of Formula 1-1.
    [화학식 1-1][Formula 1-1]
    Figure PCTKR2020014955-appb-I000014
    Figure PCTKR2020014955-appb-I000014
    상기 화학식 1-1에서,In Formula 1-1,
    p 또는 q는 각각 0 내지 10의 정수임.p or q are each an integer of 0 to 10.
  2. 제 1항에 있어서,The method of claim 1,
    상기 화학식 1에서 n은 1 내지 10,000의 정수이고, X1~X4은 적어도 하나 이상의 화학식 1-1의 치환기를 포함하며, 상기 화학식 1-1에서 p 또는 q는 각각 0 내지 10의 정수인 것을 특징으로 하는 화합물.In Formula 1, n is an integer of 1 to 10,000, X 1 to X 4 include at least one substituent of Formula 1-1, and p or q in Formula 1-1 is an integer of 0 to 10, respectively. Compound.
  3. 제 1항에 있어서,The method of claim 1,
    상기 화학식 1로 표시되는 화합물은,The compound represented by Formula 1,
    하기 화학식 2로 표시되는 화합물인 것을 특징으로 하는 화합물:A compound characterized by being a compound represented by the following formula (2):
    [화학식 2][Formula 2]
    Figure PCTKR2020014955-appb-I000015
    Figure PCTKR2020014955-appb-I000015
    상기 화학식 2에서, n은 1 내지 10,000의 정수임.In Formula 2, n is an integer of 1 to 10,000.
  4. 제 1항 내지 제 3항 중 어느 한 항의 화합물을 포함하며, 광가교 반응을 통해 형성되는 것을 특징으로 하는 하이드로젤.A hydrogel comprising the compound of any one of claims 1 to 3 and formed through a photocrosslinking reaction.
  5. 제 1항 내지 제 3항 중 어느 한 항의 화합물을 포함하는 생분해성 조직 접착제.A biodegradable tissue adhesive comprising the compound of any one of claims 1 to 3.
  6. 제 5항에 있어서,The method of claim 5,
    상기 화합물은 광에 의해 가교 반응이 일어나 하이드로젤(hydrogel)을 형성하는 것을 특징으로 하는 생분해성 조직 접착제.The compound is a biodegradable tissue adhesive, characterized in that the crosslinking reaction by light to form a hydrogel (hydrogel).
  7. 하기 화학식 1로 표시되는 화합물에 히알루론산 메타크릴레이트(Hyaluronic acid methacrylate; HAMA) 화합물을 더 혼합하는 것을 특징으로 하는 조성물:A composition, characterized in that a hyaluronic acid methacrylate (HAMA) compound is further mixed with the compound represented by the following formula (1):
    [화학식 1][Formula 1]
    Figure PCTKR2020014955-appb-I000016
    Figure PCTKR2020014955-appb-I000016
    상기 화학식 1에서, In Formula 1,
    n은 1 내지 10,000의 정수이고, X1~X4은 각각 동일하거나 다를 수 있으며, OH 또는 화학식 1-1의 치환기임.n is an integer of 1 to 10,000, and X 1 to X 4 may be the same or different, respectively, and are OH or a substituent of Formula 1-1.
    [화학식 1-1][Formula 1-1]
    Figure PCTKR2020014955-appb-I000017
    Figure PCTKR2020014955-appb-I000017
    상기 화학식 1-1에서,In Formula 1-1,
    p 또는 q는 각각 0 내지 10의 정수임.p or q are each an integer of 0 to 10.
  8. 제 7항에 있어서,The method of claim 7,
    상기 화학식 1로 표시되는 화합물은,The compound represented by Formula 1,
    하기 화학식 2 또는 화학식 3으로 표시되는 화합물인 것을 특징으로 하는 조성물:A composition characterized in that it is a compound represented by the following formula (2) or formula (3):
    [화학식 2][Formula 2]
    Figure PCTKR2020014955-appb-I000018
    Figure PCTKR2020014955-appb-I000018
    상기 화학식 2에서, n은 1 내지 10,000의 정수임.In Formula 2, n is an integer of 1 to 10,000.
    [화학식 3][Formula 3]
    Figure PCTKR2020014955-appb-I000019
    Figure PCTKR2020014955-appb-I000019
    상기 화학식 3에서, n은 1 내지 10,000의 정수임.In Formula 3, n is an integer of 1 to 10,000.
  9. 제 7항에 있어서,The method of claim 7,
    상기 HAMA와 화학식 1로 표시되는 화합물은 10:0 내지 5:5의 중량비율로 혼합되는 것을 특징으로 하는 조성물.The composition characterized in that the HAMA and the compound represented by Formula 1 are mixed in a weight ratio of 10:0 to 5:5.
  10. 제 7항 내지 제 9항 중 어느 한 항의 조성물을 포함하며, 광가교 반응을 통해 형성되는 것을 특징으로 하는 하이드로젤.A hydrogel comprising the composition of any one of claims 7 to 9 and formed through a photocrosslinking reaction.
  11. 제 7항 내지 제 9항 중 어느 한 항의 조성물을 포함하는 생분해성 조직 접착제.Biodegradable tissue adhesive comprising the composition of any one of claims 7 to 9.
  12. 제 11항에 있어서,The method of claim 11,
    상기 조성물은 광에 의해 가교 반응이 일어나 하이드로젤(hydrogel)을 형성하는 것을 특징으로 하는 생분해성 조직 접착제.The composition is a biodegradable tissue adhesive, characterized in that a crosslinking reaction occurs by light to form a hydrogel.
PCT/KR2020/014955 2019-10-31 2020-10-31 Manufacture of photo-crosslinkable biodegradable tissue adhesive WO2021086081A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2019-0137871 2019-10-31
KR20190137871 2019-10-31
KR1020200142804A KR102515178B1 (en) 2019-10-31 2020-10-30 Preparation of photo-crosslinkable biodegradable tissue adhesive
KR10-2020-0142804 2020-10-30

Publications (1)

Publication Number Publication Date
WO2021086081A1 true WO2021086081A1 (en) 2021-05-06

Family

ID=75715402

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/014955 WO2021086081A1 (en) 2019-10-31 2020-10-31 Manufacture of photo-crosslinkable biodegradable tissue adhesive

Country Status (1)

Country Link
WO (1) WO2021086081A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130231474A1 (en) * 2010-11-18 2013-09-05 Universite Joseph Fourier - Grenoble 1 Polysaccharide derivatives including an alkene unit and thiol-click chemical coupling reaction
CN103724455A (en) * 2013-12-11 2014-04-16 四川大学 Hyaluronic acid derivative and preparation method for hyaluronic acid hydrogel
WO2014072330A1 (en) * 2012-11-06 2014-05-15 Centre National De La Recherche Scientifique (Cnrs) Glucose responsive hydrogel comprising pba-grafted hyaluronic acid (ha)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130231474A1 (en) * 2010-11-18 2013-09-05 Universite Joseph Fourier - Grenoble 1 Polysaccharide derivatives including an alkene unit and thiol-click chemical coupling reaction
WO2014072330A1 (en) * 2012-11-06 2014-05-15 Centre National De La Recherche Scientifique (Cnrs) Glucose responsive hydrogel comprising pba-grafted hyaluronic acid (ha)
CN103724455A (en) * 2013-12-11 2014-04-16 四川大学 Hyaluronic acid derivative and preparation method for hyaluronic acid hydrogel

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHANDRASEKHARAN AJEESH, SEONG KEUM-YONG, YIM SANG-GU, KIM SODAM, SEO SUNGBAEK, YOON JINHWAN, YANG SEUNG YUN: "In situ photocrosslinkable hyaluronic acid-based surgical glue with tunable mechanical properties and high adhesive strength", JOURNAL OF POLYMER SCIENCE PART A: POLYMER CHEMISTRY, JOHN WILEY & SONS, INC., US, vol. 57, no. 4, 7 December 2018 (2018-12-07), US, pages 522 - 530, XP055807154, ISSN: 0887-624X, DOI: 10.1002/pola.29290 *
SHIRZAEI SANI EHSAN, PORTILLO-LARA ROBERTO, SPENCER ANDREW, YU WENDY, GEILICH BENJAMIN M., NOSHADI IMAN, WEBSTER THOMAS J., ANNABI: "Engineering Adhesive and Antimicrobial Hyaluronic Acid/Elastin-like Polypeptide Hybrid Hydrogels for Tissue Engineering Applications", ACS BIOMATERIALS SCIENCE & ENGINEERING, AMERICAN CHEMICAL SOCIETY, US, vol. 4, no. 7, 27 April 2018 (2018-04-27), US, pages 2528 - 2540, XP055807162, ISSN: 2373-9878, DOI: 10.1021/acsbiomaterials.8b00408 *
VAN NIEUWENHOVE INE; VAN VLIERBERGHE SANDRA; SALAMON ACHIM; PETERS KIRSTEN; THIENPONT HUGO; DUBRUEL PETER: "Photo-crosslinkable biopolymers targeting stem cell adhesion and proliferation: the case study of gelatin and starch-based IPNs", JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE, SPRINGER NEW YORK LLC, UNITED STATES, vol. 26, no. 2, 6 February 2015 (2015-02-06), United States, pages 1 - 8, XP035443088, ISSN: 0957-4530, DOI: 10.1007/s10856-015-5424-4 *

Similar Documents

Publication Publication Date Title
WO2018080221A1 (en) Biocompatible hydrogel and method for producing same
WO2018186575A1 (en) Photo-cross-linkable shape-memory polymer and preparation method therefor
WO2021090997A1 (en) Photo-crosslinked hyaluronic acid sponge and manufacturing method thereof
WO2016159734A1 (en) Bleed-free injection needle coated with crosslinked chitosan having introduced catechol group and oxidized catechol group
WO2018026204A1 (en) Method for preparing sustained-release oxygen omission type in situ cross-linked hydrogel using calcium peroxide and biomedical use thereof
WO2021086081A1 (en) Manufacture of photo-crosslinkable biodegradable tissue adhesive
EP3412273A1 (en) Root canal treatment material and kit for root canal treatment
WO2016163741A1 (en) Polymer containing aziridine and method for producing same
WO2011090255A2 (en) Highly injectable calcium-based bone cement composition
WO2016195152A1 (en) Method for manufacturing collagen film using ultraviolet light, collagen film manufactured by using same, and biomaterial prepared using collagen film
WO2021086072A1 (en) Manufacture of photo-crosslinkable biodegradable tissue adhesive using copolymer
WO2019074314A1 (en) Hydrogel comprising cross-linked product of graft copolymer and method for preparing same
KR102515178B1 (en) Preparation of photo-crosslinkable biodegradable tissue adhesive
WO2023282658A1 (en) Composition for preparing multi-crosslinked temperature-sensitive hydrogel, and use thereof
WO2022108264A1 (en) Photo-cross-linking copolymerized hyaluronic acid sponge and preparation method therefor
JP2003506503A (en) Organic polymer
WO2022154645A1 (en) Biocompatible hydrogel comprising component containing hyaluronic acid, polyethylene glycol and silicone
WO2019039858A1 (en) Adhesive composition, adhesive comprising same, and manufacturing method therefor
WO2018190647A2 (en) Self-healing functional polyvinyl-based compound and preparation method thereof
US6890998B2 (en) Thiol activation of polyurethanes and methods of making the same
KR102415181B1 (en) Preparation of photo-crosslinkable biodegradable tissue adhesive using copolymer
WO2009134042A2 (en) Arborescent oligopeptide-containing cyclotriphosphazene, preparation method thereof and drug delivery system containing the same
WO2022124610A1 (en) Photocurable hemostatic composition
CA3152373A1 (en) Steam sterilization of hydrogels crosslinked by beta-eliminative linkers
WO2023013964A1 (en) Composition for preparing organic-inorganic complex hydrogel and kit for preparing organic-inorganic complex hydrogel comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20881126

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20881126

Country of ref document: EP

Kind code of ref document: A1